Wedbush Keeps Their Hold Rating on Omeros Corp (OMER)

Wedbush analyst Liana Moussatos reiterated a Hold rating on Omeros Corp (OMER – Research Report) today and set a price target of $18. The company’s shares opened today at $18.56. According to More »

NGM Biopharmaceuticals Inc (NGM) Receives a Buy from Cowen & Co.

Cowen & Co. analyst Ritu Baral maintained a Buy rating on NGM Biopharmaceuticals Inc (NGM – Research Report) today and set a price target of $25. The company’s shares closed on Friday More »